# Combined single-cell transcriptome and immune repertoire analysis reveals hepatic and renal immune injury by heat stroke

**Authors:** Min Zhang, Bin Wang, Ding Sun, Xizhao Chen, Yena Zhou, Jin Yao, Liwen Du, Zehao Zhang, Hao Li, Zeyu Qu, Lu Chen, Qing Luo, Jie Zhang, Xinye Jin, Xiaowei Cheng, Jingxue Niu, Qinrui Xing, Xuezeng Tan, Tao Wang, Jie Liu, Lei Li, Qing Song, Xiangmei Chen, Yizhi Chen

PMC · DOI: 10.1172/jci.insight.189825 · JCI Insight · 2026-03-23

## TL;DR

This study explores immune responses in heat stroke patients, revealing key immune cells and pathways linked to liver and kidney injury.

## Contribution

The study identifies novel peripheral immune signatures and highlights the NLRP3 inflammasome as a potential therapeutic target for heat stroke.

## Key findings

- Granzyme-positive T cells and CD56dim NK cells with high cytotoxicity are enriched in heat stroke patients.
- IL-1B+NLRP3+ monocytes with high inflammation and pyroptosis scores are associated with heat stroke.
- Blocking the NLRP3 inflammasome pathway may reduce organ injury in heat stroke.

## Abstract

Heat stroke (HS) is the most severe heat-related emergency, and its pathophysiology remains largely unknown, especially for exertional HS (EHS), which affects younger populations, athletes, and manual workers. Herein, we performed single-cell-transcriptomics, T cell receptor sequencing, and flow cytometry of PBMCs from 9 healthy control participants, 9 patients with heat exhaustion, and 9 patients with EHS to explore complex immunological responses associated with HS pathobiology. We showcased that granzyme-positive T cells and CD56dim NK cells with high cytotoxicity features and IL-1B+NLRP3+ monocytes with high inflammation and pyroptosis scores were enriched in HS, while the CD161+ T cells with innate immune-like, low cytotoxicity, and clonal expansion features were reduced in HS. Importantly, elevated granzyme-positive T and NK cells might interact with monocytes to induce pyroptosis of hepatic and renal cells and target organ injuries, and blocking the NLRP3 inflammasome pathway prior to the induction could alleviate organ injury in HS. This study offers deeper insights into the pathogenesis of HS, supporting the development of optimal treatment strategies.

This study provides with novel peripheral immune signitures of patients with heatstroke, identifying NLRP3 as novel intervention targets for treatment.

## Linked entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], IL1B (interleukin 1 beta) [NCBI Gene 3553]
- **Proteins:** granzyme (granzyme K-like), NCAM1 (neural cell adhesion molecule 1), KLRB1 (killer cell lectin like receptor B1)
- **Diseases:** exertional heat stroke (MONDO:0018752)

## Full-text entities

- **Genes:** TCF7 (transcription factor 7) [NCBI Gene 6932] {aka TCF-1}, MT1E (metallothionein 1E) [NCBI Gene 4493] {aka MT-1E, MT-IE, MT1, MTD}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, CEMIP2 (cell migration inducing hyaluronidase 2) [NCBI Gene 23670] {aka TMEM2}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CD7 (CD7 molecule) [NCBI Gene 924] {aka GP40, LEU-9, TP41, Tp40}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IFIT2 (interferon induced protein with tetratricopeptide repeats 2) [NCBI Gene 3433] {aka G10P2, GARG-39, IFI-54, IFI-54K, IFI54, IFIT-2}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, CD247 (CD247 molecule) [NCBI Gene 919] {aka CD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, IMD25}, Zbp1 (Z-DNA binding protein 1) [NCBI Gene 58203] {aka 2010010H03Rik, Dai, Dlm1, mZaDLM}, GZMA (granzyme A) [NCBI Gene 3001] {aka CTLA3, HFSP}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CASP4 (caspase 4) [NCBI Gene 837] {aka CASP-4, ICE(rel)II, ICEREL-II, ICH-2, Mih1, Mih1/TX}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, GSDMB (gasdermin B) [NCBI Gene 55876] {aka GSDMB-1, GSDML, PP4052, PRO2521}, OLFM4 (olfactomedin 4) [NCBI Gene 10562] {aka GC1, GW112, OLM4, OlfD, UNQ362, bA209J19.1}, IL1R2 (interleukin 1 receptor type 2) [NCBI Gene 7850] {aka CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c}, TRAPPC10 (trafficking protein particle complex subunit 10) [NCBI Gene 7109] {aka EHOC-1, EHOC1, GT334, NEDMISS, TMEM1, TRS130}, FGFBP2 (fibroblast growth factor binding protein 2) [NCBI Gene 83888] {aka HBP17RP, KSP37}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931] {aka B1, Bp35, CD20, CVID5, FMC7, LEU-16}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Lhx2 (LIM homeobox protein 2) [NCBI Gene 16870] {aka LH2A, Lh-2, Lim2, ap, apterous}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, CRYGC (crystallin gamma C) [NCBI Gene 1420] {aka CCL, CRYG3, CTRCT2}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, IL18R1 (interleukin 18 receptor 1) [NCBI Gene 8809] {aka CD218a, CDw218a, IL-18R, IL-18R-alpha, IL-18Ralpha, IL-1Rrp}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, ZBP1 (Z-DNA binding protein 1) [NCBI Gene 81030] {aka C20orf183, DAI, DLM-1, DLM1}, LILRA4 (leukocyte immunoglobulin like receptor A4) [NCBI Gene 23547] {aka CD85g, ILT7}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, FCN1 (ficolin 1) [NCBI Gene 2219] {aka FCNM}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, NKG7 (natural killer cell granule protein 7) [NCBI Gene 4818] {aka GIG1, GMP-17, p15-TIA-1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, MZB1 (marginal zone B and B1 cell specific protein) [NCBI Gene 51237] {aka MEDA-7, PACAP, pERp1}, IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572] {aka CD130, CDW130, GP130, HIES4, HIES4A, HIES4B}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, HBA1 (hemoglobin subunit alpha 1) [NCBI Gene 3039] {aka ECYT7, HBA-T3, HBH, METHBA}, MRPL47 (mitochondrial ribosomal protein L47) [NCBI Gene 57129] {aka CGI-204, L47mt, MRP-L47, NCM1, uL29m}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434] {aka C56, G10P1, IFI-56, IFI-56K, IFI56, IFIT-1}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}
- **Diseases:** liver injury (MESH:D017093), CHS (MESH:D002609), necrosis (MESH:D009336), HE (MESH:D006359), fever (MESH:D005334), hepatic/renal dysfunction (MESH:D008107), Inflammation (MESH:D007249), rhabdomyolysis (MESH:D012206), circulation failure (MESH:D051437), autoimmune disorders (MESH:D001327), coagulation (MESH:D001778), systemic lupus erythematosus (MESH:D008180), hepatic injury (MESH:D056486), hepatic and renal immune injury (MESH:D058186), MODS (MESH:D009102), clinical abnormalities (MESH:D013568), cancer (MESH:D009369), multiorgan tissue damage (MESH:D017695), organ damage (MESH:D000092124), EHS (MESH:D018882), hepatocellular carcinoma (MESH:D006528), SIRS (MESH:D018746), cytotoxic (MESH:D064420), Sjogren syndrome (MESH:D012859), hypercytokinemia (MESH:D000080424), CNS abnormalities (MESH:D002493), vasculitis (MESH:D014657), gastrointestinal manifestations (MESH:D005767), infection (MESH:D007239), bleeding (MESH:D006470), injuries (MESH:D014947), DIC (MESH:D004211), HL (MESH:C538324), and renal (MESH:D006030), renal injury (MESH:D007674), dry skin (MESH:D015352), HRDs (MESH:D018883)
- **Chemicals:** urea (MESH:D014508), water (MESH:D014867), 7-AAD (MESH:C025942), creatinine (MESH:D003404), paraffin (MESH:D010232), PBS (MESH:D007854), H&amp;E (MESH:D006371), bilirubin (MESH:D001663), paraformaldehyde (MESH:C003043), Z (MESH:C000597310), EDTA (MESH:D004492), ACMEC (-), acids (MESH:D000143), sodium pentobarbital (MESH:D010424)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043102/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043102/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043102/full.md

---
Source: https://tomesphere.com/paper/PMC13043102